These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20812353)

  • 1. Emerging genes associated with the progression of nonalcoholic fatty liver disease.
    Koutsari C; Lazaridis KN
    Hepatology; 2010 Sep; 52(3):807-10. PubMed ID: 20812353
    [No Abstract]   [Full Text] [Related]  

  • 2. Methodological concerns about a recent meta-analysis of the influence of the I148M variant of patatin-like phospholipase domain containing 3 on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Liu L; Shao JH; Wang K; Hua FZ
    Hepatology; 2011 Jun; 53(6):2145; author reply 2146-7. PubMed ID: 21465506
    [No Abstract]   [Full Text] [Related]  

  • 3. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
    Speliotes EK; Butler JL; Palmer CD; Voight BF; ; ; ; Hirschhorn JN
    Hepatology; 2010 Sep; 52(3):904-12. PubMed ID: 20648472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease liver fat score and fat equation to predict and quantitate hepatic steatosis: promising but not prime time!
    Chalasani N
    Gastroenterology; 2009 Sep; 137(3):772-5. PubMed ID: 19638269
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Richart C; Auguet T; Terra X
    N Engl J Med; 2010 Jul; 363(2):193-4; author reply 195. PubMed ID: 20647217
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease.
    Daly AK; Ballestri S; Carulli L; Loria P; Day CP
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):253-63. PubMed ID: 21476920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of genes in nonalcoholic fatty liver disease.
    Day CP
    Clin Liver Dis; 2004 Aug; 8(3):673-91, xi. PubMed ID: 15331069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
    Dongiovanni P; Valenti L; Rametta R; Daly AK; Nobili V; Mozzi E; Leathart JB; Pietrobattista A; Burt AD; Maggioni M; Fracanzani AL; Lattuada E; Zappa MA; Roviaro G; Marchesini G; Day CP; Fargion S
    Gut; 2010 Feb; 59(2):267-73. PubMed ID: 20176643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?
    Dubuquoy C; Burnol AF; Moldes M
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):30-5. PubMed ID: 22884299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.
    Valenti L; Nobili V; Fargion S
    N Engl J Med; 2010 Jul; 363(2):194; author reply 195. PubMed ID: 20653077
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine.
    Sookoian S; Pirola CJ
    Clin Liver Dis; 2012 Aug; 16(3):467-85. PubMed ID: 22824476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of hepatic lipase gene promoter polymorphism -514C/T with nonalcoholic fatty liver disease].
    Zhan Q; Li YY; Nie YQ; Zhou YJ; DU YL; Sha WH; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):375-8. PubMed ID: 18510853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH).
    Sazci A; Ergul E; Aygun C; Akpinar G; Senturk O; Hulagu S
    Cell Biochem Funct; 2008 Apr; 26(3):291-6. PubMed ID: 17563923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and the PNPLA3 gene.
    Houghton-Rahrig L; Schutte D; Fenton JI; Awad J
    Medsurg Nurs; 2014; 23(2):101-6, 121. PubMed ID: 24933787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.
    Ballestri S; Day CP; Daly AK
    Gastroenterology; 2011 May; 140(5):1694-5. PubMed ID: 21439984
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease.
    Adams LA; Angulo P; Lindor KD
    CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China.
    Li Y; Xing C; Cohen JC; Hobbs HH
    Hepatology; 2012 Jan; 55(1):327-8. PubMed ID: 21898508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.